A recently published study in the Journal of the American Medical Association Pediatrics, based in part on research from the Children’s Hospital of Michigan part of the Detroit Medical Center, shows that oral antibiotics are just as effective as those delivered intravenously to children struggling with osteomyelitis.  

When it comes to the future of medicine, small is indeed beautiful. Working at the nanoscale, tens of thousands of researchers are in a race to develop tiny nanoparticles, nanodevices and nanopatterned surfaces for medical applications. Their goals are both comprehensive and ambitious. They are hoping to create drugs that stop disease processes at the molecular level where they start, engineer drug delivery systems that are small enough to reach deep within the body and build scaffolding and textured surfaces that the body can use to regenerate lost or damaged tissue.

The drugs were designed to keep cancer cells at bay by preventing their growth, survival and spread. Yet, after clinical trials, they left scientists scratching their heads and drug developers watching their investments succumb to cancer’s latest triumph.

The central regions of many glittering galaxies, our own Milky Way included, harbor cores of impenetrable darkness—black holes with masses equivalent to millions, or even billions, of suns. What is more, these supermassive black holes and their host galaxies appear to develop together, or "co-evolve." Theory predicts that as galaxies collide and merge, growing ever more massive, so too do their dark hearts.

Just as the Navy was deploying a laser weapon to the Persian Gulf, a Clemson University researcher already was thinking about how to make it more powerful.

It's a wonder new medications are ever developed at all. Taking a new drug from promising molecule to marketable product can cost upwards of a billion dollars and take a decade or more to move from clinical trials to approval. And the overall failure rate hovers near 95 percent.

A collaboration between Cornell University and the Kitchen Theatre Company (KTC) has found a new way to make physics irresistible, with “Physics Fair,” an original musical theater production.

Step-by-step observations will help scientists enhance bone-marrow transplants.

New data and assessments suggest that resilience of the planet is now at risk.

Florida State University’s Center for Advanced Power Systems has unveiled a new 24,000-volt direct current power test system, the most powerful of its kind available at a university research center throughout the world.

New family of materials produces "twin" electrical charges on single molecules, potentially paving the way for easy manufacture of more efficient solar devices.

A new study by Dana-Farber Cancer Institute investigators demonstrates that vitamin D can protect some people with colorectal cancer by perking up the immune system’s vigilance against tumor cells.